Weight-loss drugs replacing some surgeries, but doctors say they're 'not a miracle drug'
Researchers looked at the health records of 17 million Americans with obesity and determined that between 2022 and 2023, ...
Skye Bioscience Surpasses 50% Patient Enrollment in Phase 2 Obesity Study of Differentiated CB1 Inhibitor
This clinical trial is a randomized, double-blind study designed to enroll 120 patients across four treatment groups. The primary endpoint will evaluate the difference in weight loss of nimacimab ...
Wyoming News16d
Most Patients Can Keep Using GLP-1 Weight Loss Meds Before Surgeries
Concerns over delayed stomach emptying and possible aspiration risk had some doctors thinking that people taking GLP-1 meds should discontinue the meds before a surgery However, stopping the drugs ...
KTBS16d
Most Patients Can Keep Using GLP-1 Weight Loss Meds Before Surgeries
anesthesiologists and gastroenterologists affirms that most people taking popular GLP-1 weight-loss meds can keep taking them in the weeks before a surgery. It was thought that this slowdown might ...
The Laconia Daily Sun16d
Most Patients Can Keep Using GLP-1 Weight Loss Meds Before Surgeries
anesthesiologists and gastroenterologists affirms that most people taking popular GLP-1 weight-loss meds can keep taking them in the weeks before a surgery. It was thought that this slowdown might ...
Yardbarker21d
6 burning Minnesota Vikings questions from DL vs. CB to Anthony Edwards in the NFL
This is a great question. As far as the trade deadline, I've written quite a bit about it, including top-tier players to target and some that won't cost as much.Even after the Rams game, it's not ...
Mint21d
Tesla gains 4% to extend Q3-powered rally after best single-day gain in a decade; Nasdaq up 1.29%
Nasdaq Composite rose 1.29 per cent to 18,653 points in Friday's session, compared to 18,415.49 points at the previous market close. Mint reported on Thursday that Tesla shares surged 19 per cent ...